Speaker illustration

Doctor Mahendra Sibartie

Amgen, Uxbridge (United Kingdom of Great Britain & Northern Ireland)

High long-term persistence to evolocumab treatment regimens in European clinical practice: analysis of the HEYMANS registry

Event: ESC Congress 2022

Topic: Lipid-Lowering Agents

Session: Current issues in lipid-lowering therapy

Thumbnail

This platform is supported by

logo Novo Nordisk